QQ客服 官方微博 反馈留言

	Entecavir and Low Genetic Barrier Antiviral Agents for Hepatocellular Carcinoma in Hepatitis B Viral Cirrhosis: Propensity Score Matching
	Li, Tao; Qu, Yundong; Wang, Yan; Lin, Chunlei; Yang, Baohua; Wang, Lei
刊名	JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN
	2019
卷号	29期号:4页码:317-323
关键词	Hepatocellular carcinoma Liver cirrhosis Hepatitis B virus Entecavir Comparative effectiveness research
DOI	10.29271/jcpsp.2019.04.317
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4547817
专题	山东大学
作者单位	Shandong Univ, Hosp 2, Dept Infect Dis & Hepatol, 247 Beiyuan Rd, Jinan 25003
推荐引用方式 GB/T 7714	Li, Tao,Qu, Yundong,Wang, Yan,et al. Entecavir and Low Genetic Barrier Antiviral Agents for Hepatocellular Carcinoma in Hepatitis B Viral Cirrhosis: Propensity Score Matching[J]. JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN,2019,29(4):317-323.
APA	Li, Tao,Qu, Yundong,Wang, Yan,Lin, Chunlei,Yang, Baohua,&Wang, Lei.(2019).Entecavir and Low Genetic Barrier Antiviral Agents for Hepatocellular Carcinoma in Hepatitis B Viral Cirrhosis: Propensity Score Matching.JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN,29(4),317-323.
MLA	Li, Tao,et al."Entecavir and Low Genetic Barrier Antiviral Agents for Hepatocellular Carcinoma in Hepatitis B Viral Cirrhosis: Propensity Score Matching".JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN 29.4(2019):317-323.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。